Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.

Johanna Nagel, Göran Jönsson, Jan-Åke Nilsson, C Manuswin, Martin Englund, Tore Saxne, Meliha C Kapetanovic

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.”. Tillsammans bildar de ett unikt fingeravtryck.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology